Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and... see more

TSXV:THRM - Post Discussion

Therma Bright Inc > RE: A MUST read........
View:
Post by Smokey1958 on Dec 17, 2020 8:19am

RE: A MUST read........

Comments posted by bashers, the uninformed or those running with panic because they won't do due diligence. This is old NEWS. Wallpaper called it "a game changer" ....not a chance. Why?

Xpert Xpress SARS-CoV-2 is a rapid test, that much is true. BUT, it's not widely used in the US nor would/will it be in Canada. The biggest reason, it requires a nasopharyngeal swab. From the FDA product acceptance page the following....

"...the Xpert Xpress SARS-CoV-2 test is intended for use by trained operators who are proficient in performing tests..."

It can only be performed in a clinical setting and is not cheap at $20US. This product and the company were dumped on because they were trying to market it to developing nations for the same price.

CoviSafe will be the GAME CHANGER!
Comment by wallpaper2 on Dec 17, 2020 9:24am
Not targeting US or Canada. They already have many approved products in Europe and have a great deal of experience and success with their approval process. They have a distribution network in use already, will sell for $18 and be on the market early in 2021.
Comment by 420sleep on Dec 17, 2020 9:28am
Think I'll stick to DM.V instead they are already selling 9000 tests a week to the film industry and are in the process or signing the air canada deal with shoppers. There's the Tip of the week!! If anyone wants to put there Pom poms down and make real money imao
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities